Studies on the Antibacterial Effects of Statins - In Vitro and In Vivo

• Peter Bergman ,

  * E-mail: peter.bergman@ki.se

  Affiliations Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden, Department of Medicine, Centre for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Charlotte Linde,

  Affiliation Microbiology and Tumorbiology Centre (MTC), Karolinska Institutet, Stockholm, Sweden

  ⨯
• Katrin Pütsep,

  Affiliation Microbiology and Tumorbiology Centre (MTC), Karolinska Institutet, Stockholm, Sweden

  ⨯
• Anton Pohanka,

  Affiliation Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden

  ⨯
• Staffan Normark,

  Affiliation Microbiology and Tumorbiology Centre (MTC), Karolinska Institutet, Stockholm, Sweden

  ⨯
• Birgitta Henriques-Normark,

  Affiliations Microbiology and Tumorbiology Centre (MTC), Karolinska Institutet, Stockholm, Sweden, Clinical Microbiology, Karolinska University Hospital, Solna, Stockholm, Sweden

  ⨯
• Jan Andersson,

  Affiliation Department of Medicine, Centre for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Linda Björkhem-Bergman

  Affiliation Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden

  ⨯